Kanglexin attenuates spinal cord injury by modulating pyroptosis and polarization via the PKA/NF-κB signaling pathway
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114401 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Rongbao Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China; NHC Key Laboratory of Cell Transplantation, The…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Neuroprotective Agents, Anti-Inflammatory Agents, Anthraquinones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Harbin Medical University.
Abstract (Originalsprache)
BACKGROUND: Neuroinflammation is essential for intricate pathophysiologic mechanisms after spinal cord injury (SCI). Increasing evidence suggests that anthraquinones possess anti-inflammatory properties in central nervous system (CNS) disorders. However, the effects of Kanglexin (Klx), a novel synthetic anthraquinone compound, on SCI remain unknown. METHODS: C57BL/6 mice were utilized to establish a contused SCI model to explore the in vivo neuroprotective and inflammatory modulatory effects of Klx. An inflammation model was also created in vitro using BV2 cells. Neuroprotective effects were assessed by evaluating motor function and neuropathologic alterations. Inflammation modulation was analyzed through markers of polarization and pyroptosis, with further mechanistic insights obtained via transcriptome sequencing. RESULTS: Klx facilitated the recovery of hindlimb locomotor function and improved neuronal survival after SCI. Both in vitro and in vivo assays revealed that Klx inhibited NLRP3 inflammasome-induced pyroptosis. In addition, Klx promoted the polarization of microglia from the proinflammatory M1 phenotype to the anti-inflammatory M2 phenotype. Mechanistically, Klx enhanced PKA phosphorylation and suppressed NF-κB and IκBα phosphorylation, thereby reducing NF-κB nuclear translocation. CONCLUSION: Klx demonstrated neuroprotective and inflammation-modulating effects on SCI, suggesting that it might offer a promising therapeutic alternative for SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China; NHC Key Laboratory of Cell Transplantation, The First Affiliated Hospital of Harbin Medical University, Harbin, China…
- Department of Pharmacy (The University Key Laboratory of Drug Research, Heilongjiang Province), The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: yuanye_hmu@126.com.
- NHC Key Laboratory of Cell Transplantation, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: shice@hrbmu.edu.cn.
- Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, China; NHC Key Laboratory of Etiology and Epidemiology, Harbin Medical University, Harbin, China;…
- NHC Key Laboratory of Cell Transplantation, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: liyang0119@hrbmu.edu.cn.
- Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: 809435293@qq.com.
Förderung
- Harbin Medical University
Zitieren
APA
Yan, R., Yuan, Y., Shi, C., Li, Y., Li, Y., Wang, W., & Yang, L. (2025). Kanglexin attenuates spinal cord injury by modulating pyroptosis and polarization via the PKA/NF-κB signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114401
Vancouver
Yan R, Yuan Y, Shi C, Li Y, Li Y, Wang W, et al. Kanglexin attenuates spinal cord injury by modulating pyroptosis and polarization via the PKA/NF-κB signaling pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114401
BibTeX
@article{Yan2025,
author = {Yan, Rongbao and Yuan, Ye and Shi, Ce and Li, Yang and Li, Yang and Wang, Wenbo and Yang, Lei},
title = {Kanglexin attenuates spinal cord injury by modulating pyroptosis and polarization via the PKA/NF-κB signaling pathway},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114401}
}
EUVIMED